ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VELA Vela Technologies Plc

0.0125
0.0005 (4.17%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vela Technologies Plc LSE:VELA London Ordinary Share GB00BYZ9XC29 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0005 4.17% 0.0125 0.012 0.013 0.0125 0.012 0.01 17,270,512 14:42:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 0 -378k 0.0000 N/A 1.63M
Vela Technologies Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker VELA. The last closing price for Vela Technologies was 0.01p. Over the last year, Vela Technologies shares have traded in a share price range of 0.0115p to 0.0335p.

Vela Technologies currently has 16,252,335,184 shares in issue. The market capitalisation of Vela Technologies is £1.63 million.

Vela Technologies Share Discussion Threads

Showing 7076 to 7095 of 7975 messages
Chat Pages: Latest  295  294  293  292  291  290  289  288  287  286  285  284  Older
DateSubjectAuthorDiscuss
09/9/2021
08:43
That's because you can't. The MM won't even let you out at 11p.
pwhite73
09/9/2021
08:42
I'm still in. Not sold a single share.
luckyabbeygale
09/9/2021
08:35
i would have expected the
sp to have gone up over
0.14p by now!

demark
09/9/2021
08:34
i have got it completely wrong!

the market was not
stupid, but i was!!

demark
09/9/2021
08:24
"The proportion of Serious Adverse Events (SAEs) was numerically lower in the AZD1656 group compared with the placebo group."

The placebo is an inactive drug so it cannot have any Serious Adverse Events.

You might get a dead cat bounce but don't fall for it. Leave this stock well alone.

pwhite73
09/9/2021
08:19
From the RNS under Safety and tolerability:

"The degree of glycaemic control, as measured by the need to increase baseline medication requirements or the need to add additional diabetic medications, was no different between the AZD1656 group and the placebo group. The proportion of Serious Adverse Events (SAEs) was numerically lower in the AZD1656 group compared with the placebo group. The proportion of Treatment Emergent Adverse Events (TEAE) was also no different between the groups. "

So basically, "It's six of one, half a dozen of another".. sold because I'm worried about SGSC holdings that unlock tomorrow.. GL holders/new buyers

scalpface
09/9/2021
08:09
There is nothing in the results that are not already known. If you reduce the glucose levels in diabetics it increases their chances of survival. Nothing in the results indicate why there are specifics for Covid-19. Its all waffle to allow SGS out.
pwhite73
09/9/2021
08:08
Its coming here and more with new emergency legislation . https://www.lifesitenews.com/news/739437/
aidenabettin
09/9/2021
08:08
Get out quick
kevinroe
09/9/2021
08:05
https://www.bbc.com/news/uk-england-tyne-58330796.amp
aidenabettin
09/9/2021
08:05
Clown.. haha
bullrun1
09/9/2021
08:03
If you survive 5 weeks after each jab death is less likely.Get covid and build immunity.Stuff all vaccines
aidenabettin
09/9/2021
08:03
It's in auction lol
mcrudden
09/9/2021
08:03
I'm an anti vax person. Never been tested or will use a vaccine. Although the one vela has invested in sounds the best there is.
luckyabbeygale
09/9/2021
08:02
Sells for 0.12 already
kevinroe
09/9/2021
08:01
How many millions and millions cant get rid of it?
aidenabettin
09/9/2021
08:01
0.151 paid.
luckyabbeygale
09/9/2021
07:59
It's not huge newsIt's huge ramping
kevinroe
09/9/2021
07:59
Good riddance to the rubbish vaccines already out and bring on the vaccine Vela has invested in.
luckyabbeygale
09/9/2021
07:59
Against the backdrop of a successful vaccination program in the United Kingdom, VITT has emerged as a rare but devastating complication, the study's authors said in their report. We have found that it often affects young, otherwise healthy vaccine recipients and that it is associated with a high mortality.. https://www.cnbc.com/2021/08/12/blood-clots-linked-to-astrazeneca-shot-have-22percent-mortality-rate-study.html
aidenabettin
Chat Pages: Latest  295  294  293  292  291  290  289  288  287  286  285  284  Older

Your Recent History

Delayed Upgrade Clock